Browsing Tag
Alzheimer’s Disease
56 posts
PostEra collaborates with NeuroLucent to accelerate Alzheimer’s drug discovery
In a strategic move aimed at fast-tracking the development of new treatments for Alzheimer’s disease, PostEra, a UK-based…
PostEra partners with NeuroLucent to accelerate Alzheimer’s drug development using AI and machine learning
In a significant move within the biotech industry, PostEra, a UK-based biotechnology company, has entered into a strategic…
UCB signs $2bn worth deal with Roche for AD drug candidate UCB0107
Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its…
NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company
NeuroBo Pharmaceuticals, a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a…
AgeneBio enrolls first patient in phase 3 trial for AGB101 in MCI due to Alzheimer’s Disease
AgeneBio, a leading biopharmaceutical company specialising in central nervous system (CNS) disorders, has announced the enrolment of the…
Breakthrough Alzheimer’s treatments on the horizon: New drugs and potential vaccine
Global Health Update — Promising developments in the fight against Alzheimer’s disease could significantly alter the landscape of…